Literature DB >> 11978814

Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.

Mary J Savage1, Yin-Guo Lin, John R Ciallella, Dorothy G Flood, Richard W Scott.   

Abstract

The mechanisms by which neurons and synapses are lost in Alzheimer's disease (AD) are not completely understood. To characterize potential signaling events linked to AD pathogenesis, activation-specific antibodies were used to examine mitogen-activated protein kinase (MAPK) kinase pathways at various ages in mice transgenic for human amyloid precursor protein-695 with the Swedish familial AD mutations (Tg2576) and homozygous for a P264L familial AD mutation introduced by targeting of the presenilin-1 gene (PS1(P264L)). Although the c-Jun N-terminal kinase (JNK) and p38 pathways were significantly activated in the cortex at both 7 and 12 months of age, there was no significant activation of the extracellular signal-regulated kinase pathway. MAPK kinase-4, an upstream activator of JNK, was also significantly activated at 7 and 12 months, whereas c-Jun, a downstream effector of JNK-associated apoptotic signaling, was not induced. The lack of c-Jun activation is consistent with the absence of neuronal loss in both cortex and hippocampal CA1 at 12 months. The JNK activation was localized to amyloid deposits, within neurites containing phosphorylated tau. Synaptophysin was quantified biochemically as a measure of synaptic integrity and was significantly reduced in an age-dependent manner in the Tg2576/PS1(P264L) cortex but not in either PS1(P264L) or Tg2576 cortex. Stress-responsive MAP kinase pathways were activated in the brain of the Tg2576/PS1(P264L) AD model, and this activation was coincident with the age-dependent increase in amyloid deposition, tau phosphorylation, and loss of synaptophysin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978814      PMCID: PMC6758401          DOI: 20026352

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons.

Authors:  E T Coffey; V Hongisto; M Dickens; R J Davis; M J Courtney
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway.

Authors:  I N Foltz; J C Lee; P R Young; J W Schrader
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

Review 3.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

4.  Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.

Authors:  X Zhu; A K Raina; C A Rottkamp; G Aliev; G Perry; H Boux; M A Smith
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.

Authors:  X Zhu; C A Rottkamp; H Boux; A Takeda; G Perry; M A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2000-10       Impact factor: 3.685

7.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

Authors:  T Gómez-Isla; R Hollister; H West; S Mui; J H Growdon; R C Petersen; J E Parisi; B T Hyman
Journal:  Ann Neurol       Date:  1997-01       Impact factor: 10.422

8.  Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system.

Authors:  D G Flood; J P Finn; K M Walton; C A Dionne; P C Contreras; M S Miller; R V Bhat
Journal:  J Comp Neurol       Date:  1998-08-31       Impact factor: 3.215

9.  Unbiased stereological estimation of the number of neurons in the human hippocampus.

Authors:  M J West; H J Gundersen
Journal:  J Comp Neurol       Date:  1990-06-01       Impact factor: 3.215

10.  Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury.

Authors:  T Herdegen; F X Claret; T Kallunki; A Martin-Villalba; C Winter; T Hunter; M Karin
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

View more
  99 in total

1.  Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease.

Authors:  Steven P Braithwaite; Ralf S Schmid; Dong Ning He; Mei-Li A Sung; Seongeon Cho; Lynn Resnick; Michael M Monaghan; Warren D Hirst; Christian Essrich; Peter H Reinhart; Donald C Lo
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

2.  Alzheimer's therapeutics: neurotrophin domain small molecule mimetics.

Authors:  Stephen M Massa; Youmei Xie; Frank M Longo
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 3.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

4.  Involvement of JNK in the embryonic development and organogenesis in zebrafish.

Authors:  Yamei Xiao; Yonghua Zhou; Zhen Xiong; Lijun Zou; Minggui Jiang; Zhongwen Luo; Sheng Wen; Wenbin Liu; Shaojun Liu; Wancheng Li
Journal:  Mar Biotechnol (NY)       Date:  2013-07-25       Impact factor: 3.619

5.  The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.

Authors:  Adam D Bachstetter; Linda J Van Eldik
Journal:  Aging Dis       Date:  2010-09-24       Impact factor: 6.745

6.  Intrahippocampal miR-342-3p inhibition reduces β-amyloid plaques and ameliorates learning and memory in Alzheimer's disease.

Authors:  Yin Fu; Xiaoyang Hu; Chunyu Zheng; Guicai Sun; Jianyu Xu; Shanshan Luo; Peigang Cao
Journal:  Metab Brain Dis       Date:  2019-05-27       Impact factor: 3.584

7.  5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease.

Authors:  Jin Chu; Phillip F Giannopoulos; Carolina Ceballos-Diaz; Todd E Golde; Domenico Praticò
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

8.  Interaction of ASK1 and the beta-amyloid precursor protein in a stress-signaling complex.

Authors:  Veronica Galvan; Surita Banwait; Patricia Spilman; Olivia F Gorostiza; Alyson Peel; Marina Ataie; Danielle Crippen; Wei Huang; Gurleen Sidhu; Hidenori Ichijo; Dale E Bredesen
Journal:  Neurobiol Dis       Date:  2007-07-03       Impact factor: 5.996

Review 9.  Oxidative stress signaling in Alzheimer's disease.

Authors:  B Su; X Wang; A Nunomura; P I Moreira; H-gon Lee; G Perry; M A Smith; X Zhu
Journal:  Curr Alzheimer Res       Date:  2008-12       Impact factor: 3.498

10.  Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.

Authors:  Thuy-Vi V Nguyen; Veronica Galvan; Wei Huang; Surita Banwait; Huidong Tang; Junli Zhang; Dale E Bredesen
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.